arrow
Back
R

Ross A. Soo

national university health system

69H-index
687Paper Count
1.9WCitation Count
Published Papers 165
Publication Date
Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives
err2026-08-03
err0
PREAI
errRoss A. Soo; Ji-Youn Han; James Chung-Man Ho; Calvin S.H. Ng; Lynette L.S. Teo; Elaine Shum; Sanjay Popat
errShare
errSave
Asia-Pacific practical consensus in the management of adverse events related to Amivantamab-Based therapies in Non-Small cell lung cancer
err2026-04-07
err0
PREAI
errRoss A. Soo; Pablo Fernandez-Penas; Molly Li; Pei Jye Voon; Junko Tanizaki; Jeng-Sen Tseng; Chris Tan; Xiao Rong Dong; Kumar Prabhash; Hye Ryun Kim; Kazuo Hasegawa; Nicole Parkinson; Julian Kam; Jairo Simoes; Marija McGeachie; Shun Lu; Nick Pavlakis
errShare
errSave
Emerging treatment strategies for HER2-mutant NSCLC: Striving for selectivity, efficacy, and tolerability
err2026-03-21
err0
PREAI
errGerrina Ruiter; Xiuning Le; Ross A. Soo; Noboru Yamamoto; Nicolas Girard; Yi-Long Wu; Joshua K. Sabari; Ernest Nadal
errShare
errSave
A cost-effectiveness analysis model of actionable genomic alteration testing strategies incorporating different modalities and sizes of next-generation sequencing panels in non-small-cell lung cancer
err2025-12-21
err0
PREAI
errYvonne L. E. Ang; Jian Chun Matthew Ong; Yiqing Huang; Jia Li Low; Kenneth Sooi; Jorn Nützinger; Xiao Jun Wang; Meaghan Gibbs; Boon Cher Goh; Ross A. Soo
errShare
errSave
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population
err2025-11-13
err0
errOAAI
errJing Yi Lee; Aya El Helali; Donavan Jia Jie Tan; Zi Yi Wan; Donald Poon; Jens Samol; Tsz Him So; Su Pin Choo; Ravindran Kanesvaran; Cheng-Vai Hui; Joseph Siu-Kie Au; Timothy Yip; Ross A. Soo; Michelle Pek; Ruifen Weng; Bin Tean Teh; Min-Han Tan; Jonathan Poh; Jason Yongsheng Chan
errShare
errSave
A comparison of clinical guidelines; treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America
err2025-10-27
err0
errOAAI
errChi-Lu Chiang; Ross Andrew Soo; Tony Mok; Pei Jye Voon; Lucksamon Thamlikitkul; Ying Cheng; Hidehito Horinouchi; Byong Chul Cho; Krista Lin Xu; Myung-Ju Ahn†
errShare
errSave
The 2024 International Association for the Study of Lung Cancer (IASLC) Global Survey on Biomarker Testing
err2025-07-22
err0
PREAI
errMatthew P. Smeltzer; Jennifer C. King; Casey Connolly; Kristin Brunson; Maiyan Chau; Shuyan Chen; Anna Kerpel-Fronius; Sylvie Lantuejoul; Anant Mohan; Allison Plaxco; Upal Basu Roy; Ricardo Santos; Ross Soo; Gavitt Woodard; Murry W. Wynes; Yasushi Yatabe; Amanda Young; Karen Kelly
errShare
errSave
NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies
err2025-06-09
err0
errOAAI
errJoan R. Choo; Santhiay Nathan Jeraj; Raghav Sundar; Wei Peng Yong; Matilda Lee; Yiqing Huang; Yugarajah Asokumaran; Gloria H. J. Chan; Natalie Y. L. Ngoi; Andrea L. A. Wong; Ross A. Soo; Cheng Ean Chee; Joline S. J. Lim; Boon Cher Goh; Soo Chin Lee; David S. P. Tan
errShare
errSave
A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial
err2025-04-01
err0
PREAI
errSoo, R. A.; Vervita, K.; Fruh, M.; Cho, B. C.; Majem, M.; Abreu, D. Rodriguez; Ribi, K.; Callejo, A.; Moran, T.; Gomez, M. Domine; Provencio, M.; Addeo, A.; Han, J. Y.; Granados, A. L. Ortega; Reck, M.; Blasco, A.; Campelo, R. Garcia; Gonzalez, M. A. Sala; Britschgi, C.; Roschitzki-Voser, H.; Ruepp, B.; Gasca-Ruchti, A.; Haberecker, M.; Dafni, U.; Peters, S.; Stahel, R. A.
errShare
errSave
First-Line Lorlatinib Versus Crizotinib in Asian Patients With Advanced ALK-Positive NSCLC: Five-Year Outcomes From the CROWN Study
err2025-02-28
err0
errOAAI
errYi-Long Wu; Hye Ryun Kim; Ross A. Soo; Qing Zhou; Hiroaki Akamatsu; Gee-Chen Chang; Chao-Hua Chiu; Hidetoshi Hayashi; Sang-We Kim; Yasushi Goto; Terufumi Kato; Jianying Zhou; Victor Ho-Fun Lee; Makoto Nishio; Baohui Han; Dong-Wan Kim; Shun Lu; Anna Polli; Jean-François Martini; Francesca Toffalorio; Tony Mok
errShare
errSave
Hierarchical clustering of immune checkpoint inhibitor- related pneumonitis in an Asian cohort of patients
err2024-12-01
err0
PREAI
errHuang, Y.; Lam, T.; Wong, A. S.; Zhao, J. J.; Tay, S. H.; Soo, R. . A.; Soo, Y. . Y.; Kee, A. C.
errShare
errSave
Exosome autoantibody biomarkers for detection of lung cancer
err2024-11-18
err0
errOAAI
errThuya, Win Lwin; Peyper, Janique Michelle; Myen, Tan Ti; Anuar, Nur Diana; Anwar, Arif; Gudimella, Ranga; Rutt, Nurul Huda; Rosli, Nurul Shielawati Mohamed; Badri, Noorul Hidayah; Rahman, Teh Norleila Abdul; Nurashirin, Raja; Sethi, Gautam; Tam, John Kit Chung; Wong, Andrea Li-Ann; Soo, Ross; Blackburn, Jonathan M.; Wang, Lingzhi; Goh, Boon Cher
errShare
errSave
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape
err2024-11-01
err1
errOAAI
errWeller, Michael; Remon, Jordi; Rieken, Stefan; Vollmuth, Philipp; Ahn, Myung-Ju; Minniti, Giuseppe; Le Rhun, Emilie; Westphal, Manfred; Brastianos, Priscilla K.; Soo, Ross A.; Kirkpatrick, John P.; Goldberg, Sarah B.; Ohrling, Katarina; Hegi-Johnson, Fiona; Hendriks, Lizza E. L.
errShare
errSave
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer
err2024-10-03
err0
errOAAI
errSolomon, Benjamin J.; Liu, Geoffrey; Felip, Enriqueta; Mok, Tony S. K.; Soo, Ross A.; Mazieres, Julien; Shaw, Alice T.; de Marinis, Filippo; Goto, Yasushi; Wu, Yi-Long; Kim, Dong-Wan; Martini, Jean-Francois; Messina, Rossella; Paolini, Jolanda; Polli, Anna; Thomaidou, Despina; Toffalorio, Francesca; Bauer, Todd M.
errShare
errSave
HER3 is widely expressed across diverse subtypes of NSCLC in a retrospective analysis of archived tissue samples
err2024-09-25
err0
errOAAI
errSoo, Ross A.; Clinthorne, Graham; Santhanagopal, Anu; Wu, Chuntao; Karnoub, Maha; Patel, Parul; Bubendorf, Lukas
errShare
errSave
Phase II open-label randomized study of pembrolizumab with or without bevacizumab in platinum-resistant recurrent/metastatic nasopharyngeal carcinoma (R/M NPC)
err2024-09-01
err1
PREAI
errChong, W. Q.; Low, J. L.; Sooi, K.; Soo, R. A.; Le, C.; Teo, H. L.; Samol, J.; Goh, G.; Kong, L. R.; DasGupta, R.; Chia, S.; Wong, R.; Gopinathan, A.; Tay, J. K.; Eu, D.; Tsang, R.; Loh, K-S.; Tai, B. C.; Lim, Y. C.; Goh, B-C.
errShare
errSave
First-line lorlatinib vs crizotinib in Asian patients with ALK plus non-small cell lung cancer (NSCLC): 5-year outcomes from the CROWN study
err2024-09-01
err0
PREAI
errWu, Y-L.; Kim, H. R.; Soo, R. A.; Zhou, Q.; Akamatsu, H.; Chang, G-C.; Chiu, C. H.; Hayashi, H.; Kim, S-W.; Goto, Y.; Kato, T.; Zhou, J.; Lee, V. H. F.; Nishio, M.; Han, B.; Kim, D-W.; Lu, S.; Polli, A.; Martini, J-F.; Mok, T. S. K.
errShare
errSave
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
err2024-09-01
err0
PREAI
errFelip, Enriqueta; Metro, Giulio; Soo, Ross A.; Wolf, Juergen; Solomon, Benjamin J.; Tan, Daniel S. W.; Ardizzoni, Andrea; Lee, Dae Ho; Sequist, Lecia V.; Barlesi, Fabrice; Ponce-Aix, Santiago; Abreu, Delvys Rodriguez; Campelo, Maria Rosario Garcia; Sprauten, Mette; Djentuh, Leslie O'Sullivan; Smith, Nathalie; Jary, Aline; Belli, Riccardo; Glaser, Sabine; Zou, Mike; Cui, Xiaoming; Giovannini, Monica; Yang, James Chih-Hsin
errShare
errSave
Longitudinal probing of combinatorial immunotherapy (anti-VEGF/anti-PD1) response in advanced nasopharyngeal carcinoma, at single cell resolution
err2024-09-01
err0
PREAI
errChia, S.; Shirgaonkar, N.; Lim, Y. C.; Tay, J. K.; Chong, W. Q.; Low, J. L.; Sooi, K.; Soo, R. A.; Teo, H. L.; Samol, J.; Goh, G.; Kong, L. R.; Gopinathan, A.; Eu, D.; Tsang, R.; Loh, K-S.; Tai, B. C.; Toh, H. C.; Goh, B-C.; DasGupta, R.
errShare
errSave